Steroid-responsive myopathy: Immune-mediated necrotizing myopathy or polymyositis without inflammation?

Journal of Clinical Neuromuscular Disease

Volumn 9, Issue 3, 2008, Pages 341-344

  Sadeh, Menachem ^a   Dabby, Ron ^b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Inflammatory myopathy; Necrotizing myopathy; Polymyositis; Steroid responsive myopathy

Indexed keywords

AZATHIOPRINE; CREATINE KINASE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE; STEROID;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE REDUCTION; ELECTROMYOGRAPHY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; LIMB WEAKNESS; LOW DRUG DOSE; MALE; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MYOPATHY; POLYMYOSITIS; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADOLESCENT; CREATINE KINASE; HUMANS; MALE; MUSCULAR DISEASES; NECROSIS; RECURRENCE; SEVERITY OF ILLNESS INDEX; STEROIDS;

EID: 40949149514     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e31815e5d4a     Document Type: Article

References (12)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344-347.
2. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol. 1984;16:193-208.
3. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol. 1989;20:224-231.
4. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971-982.
5. Dalakas MC, Hohlfeld R. Diagnostic criteria for polymyositis and dermatomyositis. Lancet. 2003;362:1763.
6. van der Meulen MF, Bronner IM, Hoogendijk JE, et al. Polymyositis: an overdiagnosed entity. Neurology. 2003;61:316-321.
7. Levin MI, Mozaffar T, Al-Lozi MT, et al. Paraneoplastic necrotizing myopathy: clinical and pathological features. Neurology. 1998;50:764-767.
8. Emslie-Smith AM, Engel AG. Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration. Neurology. 1991;4:936-939.
9. Bronner IM, Hoogendijk JE, Wintzen AR, et al. Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy. J Neurol. 2003;250:480-485.
10. Wulff JD, Lin JT, Kepes JJ. Inflammatory facioscapulohumeral muscular dystrophy and Coats syndrome. Ann Neurol. 1982;12:398-401.
11. Gallardo E, Rojas-Garcia R, de Luna N, et al. Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology. 2001;57:2136-2138.
12. Yabe I, Higashi T, Kikuchi S, et al. GNE mutations causing distal myopathy with rimmed vacuoles with inflammation. Neurology. 2003;61:384-386.